BICO Group AB (publ) (STO:BICO)

Market Cap	1.70B +12.6%
Revenue (ttm)	1.50B -2.5%
Net Income	-839.20M
EPS	-11.89
Shares Out	70.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,777
Open	23.45
Previous Close	23.50
Day's Range	23.45 - 24.25
52-Week Range	12.94 - 25.42
Beta	2.50
Analysts	n/a
Price Target	31.00 (+28.36%)
Earnings Date	Nov 11, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables and application...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 554
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2025, BICO Group AB's revenue was 1.50 billion, a decrease of -13.32% compared to the previous year's 1.73 billion. Losses were -1.09 billion, 19698.2% more than in 2024.

Analyst Summary

The average 12-month stock price target for BICO is kr 31.00, which is an increase of 28.36% from the latest price.

Price Target

kr 31.00

(28.36% upside)

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error